Two Sigma Securities’s Catheter Precision VTAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-933
Closed -$6.1K 2141
2025
Q1
$6.1K Buy
+933
New +$7.06K ﹤0.01% 1288
2024
Q3
Sell
-101
Closed -$11.2K 3701
2024
Q2
$11.2K Buy
+101
New +$10.3K ﹤0.01% 2796
2023
Q4
Sell
-84
Closed -$7.09K 3642
2023
Q3
$7.09K Buy
+84
New +$9.76K ﹤0.01% 2750
2022
Q4
Sell
-12
Closed -$14K 3317
2022
Q3
$14K Buy
+12
New +$22.8K ﹤0.01% 2348
2021
Q3
Sell
-2
Closed -$74K 1996
2021
Q2
$74K Buy
+2
New +$83.1K ﹤0.01% 1371

Other funds holding VTAK

Two Sigma Securities's VTAK Position: Q2 2025 in Review

Two Sigma Securities sold out of Catheter Precision (VTAK) in Q2 2025, closing a stake of 933 shares — an estimated $6.1K sold.

Two Sigma Securities first reported a position in VTAK in Q2 2021 and held it in 5 quarters. The position peaked at $74K in Q2 2021. 12 funds tracked by Wall St. Rank hold VTAK as of Q2 2025.

  • Two Sigma Securities reported no remaining Catheter Precision position as of Q2 2025 after selling out during the quarter.
  • Two Sigma Securities sold 933 Catheter Precision shares in Q2 2025, an estimated $6.1K.
  • Two Sigma Securities first reported a position in Catheter Precision in Q2 2021 and held it in 5 quarters.
  • Two Sigma Securities's Catheter Precision position peaked at $74K in Q2 2021.
  • 12 funds tracked by Wall St. Rank held Catheter Precision as of Q2 2025.

Based on Two Sigma Securities's 13F filing for Q2 2025, filed 14 Aug 2025.